Engineering

Education

Business Development

Accounting

Product Management

Operations

Support

Legal

Sales

Information Technology

Research

Quality Assurance

Healthcare Services

Finance

Program and Project Management

Entrepreneurship

Blood-based cancer detection using AI and whole-genome sequencing

Chief Technology Officer

Delfi Diagnostics Announces $225 Million in Series B

Delfi Diagnostics Gains NY State Approval for Blood-Based Lung Cancer LDT

DELFI Diagnostics Receives New York State Department of Health Clinical Laboratory Permit, Completing Authorization to Serve Health Systems Across All 50 States

Delfi Diagnostics Gives 'First Look' at Clinical Utility of cfDNA Assay in Lung Cancer Screening

Clinical Data Manager / Senior Clinical Data Manager

DELFI Diagnostics develops blood-based cancer detection tests using advanced machine-learning methods applied to whole-genome sequencing data. The contract Clinical Data Manager or Senior Clinical Data Manager will provide supplemental clinical data management capacity for the DELFI-L201 (CASCADE) IVD Clinical Validation study, focusing on data cleaning, query management, reconciliation, database lock readiness, and specification development.

Clinical Data Manager / Senior Clinical Data Manager (Contract)

Senior Data Scientist, Assay Development

DELFI Diagnostics develops blood-based, machine-learning-enabled tests to support early cancer detection. The Senior Data Scientist will develop and execute statistical analyses for assay development, analytical validation, quality control, and regulatory submissions while collaborating with laboratory, clinical, engineering, and data science teams.

Sr. Data Scientist, Assay Development

Director / Senior Director, Market Access & Reimbursement

DELFI Diagnostics develops blood-based, machine-learning-enabled tests for early cancer detection. The Director / Senior Director, Market Access & Reimbursement will own and execute the U.S. access strategy across product lines, translating clinical and health-economic evidence into coding, coverage, and payment strategies while building the market access function and team.